Physician profile
Eduardo Esper
NPI 1902890999
$4,831.89
in general payments reported to CMS, 2019-2025
30 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $99.03 · 2021: $3,758 · 2022: $167 · 2023: $87.41 · 2024: $169 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,281.34 | 2021-2024 | Signia |
| Atricure, INC. | $1,236.64 | 2021-2024 | |
| Silk Road Medical, INC. | $912.62 | 2021 | |
| Bolton Medical INC | $189.44 | 2021-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System |
| Zimmer Biomet Holdings, INC. | $141.98 | 2019-2025 | Venapax |
| Ethicon US, LLC | $128.75 | 2021-2025 | Echelon; Endopath, Echelon Flex, Echelon Endopath |
| Lemaitre Vascular, INC. | $101.90 | 2019-2025 | Xenosure Biologic Patch |
| Covidien LP | $99.44 | 2019-2020 | |
| Kls-Martin L.P. | $96.70 | 2019-2024 | |
| Zoll Medical Corporation | $85.24 | 2025 | Defibrillator |
| Ethicon INC. | $56.53 | 2021 | |
| Chiesi USA, INC. | $54.77 | 2019-2021 | |
| Getinge USA Sales, LLC | $54.37 | 2020-2023 | Acrobat-I Stabilizer |
| Baxter Healthcare | $46.69 | 2024 | Preveleak |
| Stryker Corporation | $42.50 | 2021-2025 | Na |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $32.18 | 2021 | |
| Kci USA, INC. | $30.41 | 2021-2023 | Prevena, V.A.C. Dermatac, V.A.C.Ulta |
| W. L. Gore & Associates, INC. | $29.43 | 2023-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Avanos Medical | $26.13 | 2019 | |
| Abiomed | $23.42 | 2020 | |
| Inogen, INC. | $23.41 | 2021 | |
| Solventum Corporation | $22.20 | 2025 | Prevena |
| Davol INC. | $18.36 | 2021 | |
| Genentech USA, INC. | $17.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.98 | 2021 | |
| Biotronik INC. | $14.90 | 2025 | |
| Terumo Cardiovascular Systems Corporation | $14.16 | 2019 | |
| Artivion, INC. | $13.58 | 2025 | Amds-Ascyrus Medical |
| Medline Industries LP | $11.55 | 2019 | |
| Hemosonics LLC | $8.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Esper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.